Interventional study of diltiazem in dilated cardiomyopathy: A report of multiple centre clinical trial in China. Chinese cooperative group of diltiazem intervention trial in dilated cardiomyopathy

International Journal of Cardiology

Volumn 64, Issue 1, 1998, Pages 25-30

  Liao, Yu Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Autoantibodies; Dilated cardiomyopathy; Diltiazem

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; PLACEBO;

ADULT; ARTICLE; AUTOIMMUNITY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART FAILURE; HEART FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR AGENTS; CHINA; DILTIAZEM; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; MITOCHONDRIAL ADP, ATP TRANSLOCASES; REFERENCE VALUES; SOFTWARE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032513276     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00310-0     Document Type: Article

References (9)

1. Manolio T.A., Baughman K.L., Rodeheffer R., Pearson TA., Bristow J.D., Michels V.V.et al. Prevalence and etiology of idiopthic dilate cardiomyopathy (Summary of a National Heart, Lung, and Blood Institute Workshop). Am J Cardiol. 69:1992;1458-1466.
2. Schultheiss H.P., Kuhl U., Janda I., Melzner B., Ulrich G., Morad M. Antibody-mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med. 168:1988;215-219.
3. Yuhua Liao, Yuanshu Tu, Longxian Chenget al. Cardiac cytotoxic mechanism mediated by antibodies against myocardial mitochondrial ADP/ATP carrier in patients with dilated cardiomyopathy. Chin Med J. 109:1996;193-196.
4. Liao Yu-Hua Functional analysis of autoantibodies against ADP/ATP carrier from dilated cardiomyopathy. Int J Cardiol. 54:1996;165-169.
5. Figulla H.R., Rechenberg J.V., Wiegand V., Soballa R., Kreuzer H. Beneficial effects of long-term diltiazem treatment in dilated cardiomyopathy. J Am Coll Cardiol. 13:1989;653-658.
6. Brandenburg R.O., Chozov E., Cherian G., Falase A.O.et al. Report of the WHO/ISFC Task force on the definition and classification of cardiopathies. Br Heart J. 44:1980;672-673.
7. Schultheiss H.P., Bolte H.D. Immunological analysis of autoantibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mod Cell Cardiol. 17:1985;603-617.
8. Schwimmbeck P.L., Bland N.K., Schultheiss H.P., Strauer B.E. The possible value of synthetic peptides in the diagnosis and therapy of myocarditis and dilated cardiomyopathy. Eur Heart J. 12(suppl D):1991;76-80.
9. Kuhl U., Melzner B., Schafer B., Schultheiss H.P., Strauer B.E. The Ca-channel as cardiac autoantigen. Eur Heart J. 12(suppl D):1991;99-104.